Robinson Capital Management’s Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share TCOA.WS Stock Holding History
Bought
Maintained
Sold
Robinson Capital Management's TCOA.WS Position: Q4 2024 in Review
Robinson Capital Management sold out of Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (TCOA.WS) in Q4 2024, closing a stake of 335 shares — an estimated $3 sold.
Robinson Capital Management first reported a position in TCOA.WS in Q2 2022 and held it in 9 quarters. The position peaked at $255 in Q2 2023. 1 fund tracked by Wall St. Rank holds TCOA.WS as of Q4 2024.
- Robinson Capital Management reported no remaining Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2024 after selling out during the quarter.
- Robinson Capital Management sold 335 Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2024, an estimated $3.
- Robinson Capital Management first reported a position in Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 9 quarters.
- Robinson Capital Management's Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $255 in Q2 2023.
- 1 fund tracked by Wall St. Rank held Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2024.
Based on Robinson Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.